CRUK/09/041:A Phase 1 Trial of Figitumumab, an IGFR-1R Antibody, in Children Aged 2-12 years Old with Relapsed/Refractory Solid Tumours

Project Details

Short titleCRUK/09/041:A Phase 1 Trial of Figitumumab, an IGFR-1R Antibody, in Children Aged 2-12 years Old with Relapsed/Refractory Solid Tumours
StatusFinished
Effective start/end date1/12/1030/11/12

Funding

  • Cancer Research UK